1. Volume 121, Issue 4, Pages 973-974.e2 (April 2014)
The IL-8, VEGF, and CFH Polymorphisms and Bevacizumab in Age-related Macular Degeneration 
Asta Hautamäki, MD, Jarno Kivioja, MSc, Sanna Seitsonen, MD, PhD, Eeva-Riitta Savolainen, MD, PhD, M. Johanna Liinamaa, MD, PhD, Arto Luoma, PhD, Irma Järvelä, MD, PhD, Ilkka Immonen, MD, PhD 
Ophthalmology 
Volume 121, Issue 4, Pages e2 (April 2014)
DOI: /j.ophtha
Copyright © 2014 American Academy of Ophthalmology Terms and Conditions

2. Figure 1
Distribution of the ratios of visits at which intra- or subretinal fluid was detected in relation to all visits of each patient during the 2 years follow-up in each polymorphism group and in groups of differing risk allele frequencies. Risk alleles were defined as A in IL-8 rs4073, A in VEGF rs699947, and C in CFH rs IL = interleukin; NS = nonsignificant. *P = (Kruskal Wallis), **P = 0.002, ***P = , and ****P = (Mann-Whitney U test) compared with the group with lowest sum of risk alleles.
Ophthalmology  , e2DOI: ( /j.ophtha )
Copyright © 2014 American Academy of Ophthalmology Terms and Conditions